Regulation of the mouse Treacher Collins syndrome homolog (Tcof1) promoter through differential repression of constitutive expression

DNA and Cell Biology

Volumn 27, Issue 11, 2008, Pages 589-600

  Shows, Kathryn H ^a   Shiang, Rita ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; PROTEIN TCOF1; PROTEIN ZFP161; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG; PHOSPHOPROTEIN; TCOF1 PROTEIN, HUMAN; TCOF1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL ACTIVATION; CELL DIFFERENTIATION; CHROMATIN; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENE CONTROL; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MANDIBULOFACIAL DYSOSTOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BINDING; ANIMAL; CELL LINE; CHEMISTRY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROMOTER REGION;

ANIMALS; BASE SEQUENCE; CELL LINE; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

EID: 55949086679     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0766     Document Type: Article

References (55)

1. Borchers, A., David, R., and Wedlich, D. (2001). Xenopus cadherin-11 restrains cranial neural crest migration and influences neural crest specification. Development 128, 3049-3060.
2. Dixon, J., and Dixon, M.J. (2004). Genetic background has a major effect on the penetrance and severity of craniofacial defects in mice heterozygous for the gene encoding the nucleolar protein Treacle. Dev Dyn 229, 907-914.
3. Dixon, J., Edwards, S.J., Anderson, I., Brass, A., Scambler, P.J., and Dixon, M.J. (1997a). Identification of the complete coding sequence and genomic organization of the Treacher Collins syndrome gene. Genome Res 7, 223-234.
4. Dixon, J., Hovanes, K., Shiang, R., and Dixon, M.J. (1997b). Sequence analysis, identification of evolutionary conserved motifs and expression analysis of murine tcof1 provide further evidence for a potential function for the gene and its human homologue, TCOF1. Hum Mol Genet 6, 727-737.
5. Dixon, J., Brakebusch, C., Fassler, R., and Dixon, M.J. (2000). Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome. Hum Mol Genet 9, 1473-1480.
6. Dixon, J., Jones, N.C., Sandell, L.L., Jayasinghe, S.M., Crane, J., Rey, J.P., Dixon, M.J., and Trainor, P.A. (2006). Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc Natl Acad Sci USA 103, 13403-13408.
7. Edwards, S.J., Gladwin, A.J., and Dixon, M.J. (1997). The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon. Am J Hum Genet 60, 515-524.
8. Frischmeyer, P.A., van Hoof, A., O'Donnell, K., Guerrerio, A.L., Parker, R., and Dietz, H.C. (2002). An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science 295, 2258-2261.
9. Gladwin, A.J., Dixon, J., Loftus, S.K., Edwards, S., Wasmuth, J.J., Hennekam, R.C., and Dixon, M.J. (1996). Treacher Collins syndrome may result from insertions, deletions or splicing mutations, which introduce a termination codon into the gene. Hum Mol Genet 5, 1533-1538.
10. Gonzalez, B., Henning, D., So, R.B., Dixon, J., Dixon, M.J., and Valdez, B.C. (2005). The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation. Hum Mol Genet 14, 2035-2043.
11. Gray, P.A., Fu, H., Luo, P., Zhao, Q., Yu, J., Ferrari, A., et al. (2004). Mouse brain organization revealed through direct genome-scale TF expression analysis. Science 306, 2255-2257.
12. Haworth, K.E., Islam, I., Breen, M., Putt, W., Makrinou, E., Binns, M., Hopkinson, D., and Edwards, Y. (2001). Canine TCOF1; cloning, chromosome assignment and genetic analysis in dogs with different head types. Mamm Genome 12, 622-629.
13. Hayano, T., Yanagida, M., Yamauchi, Y., Shinkawa, T., Isobe, T., and Takahashi, N. (2003). Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome. J Biol Chem 278, 34309-34319.
14. Hoeppner, M.A., Gilbert, D.J., Copeland, N.G., Jenkins, N.A., Linzer, D.I., and Wu, B. (1996). Cloning and characterization of mouse CCAAT binding factor. Nucleic Acids Res 24, 1091-1098.
15. Holemon, H., Korshunova, Y., Ordway, J.M., Bedell, J.A., Citek, R.W., Lakey, N., Leon, J., Finney, M., McPherson, J.D., and Jeddeloh, J.A. (2007). MethylScreen: DNA methylation density monitoring using quantitative PCR. Biotechniques 43, 683-693.
16. Hronek, B.W., Meagher, A., Rovnak, J., and Quackenbush, S.L. (2004). Identification and characterization of cis-acting elements residing in the walleye dermal sarcoma virus promoter. J Virol 78, 7590-7601.
17. Isaac, C., Marsh, K.L., Paznekas, W.A., Dixon, J., Dixon, M.J., Jabs, E.W., and Meier, U.T. (2000). Characterization of the nucleolar gene product, treacle, in Treacher Collins syndrome. Mol Biol Cell 11, 3061-3071.
18. Kaplan, J., and Calame, K. (1997). The ZiN=POZ domain of ZF5 is required for both transcriptional activation and repression. Nucleic Acids Res 25, 1108-1116.
19. Karafiat, V., Dvorakova, M., Krejci, E., Kralova, J., Pajer, P., Snajdr, P., Mandikova, S., Bartunek, P., Grim, M., and Dvorak, M. (2005). Transcription factor c-myb is involved in the regulation of the epithelial-mesenchymal transition in the avian neural crest. Cell Mol Life Sci 62, 2516-2525.
20. Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M., and Haussler, D. (2002). The Human Genome Browser at UCSC. Genome Res 12, 996-1006.
21. Lania, L., Majello, B., and de Luca, P. (1997). Transcriptional regulation by the Sp family proteins. Int J Biochem Cell Biol 29, 1313-1323.
22. Lefebvre, V., and Smits, P. (2005). Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 75, 200-212.
23. Lopez, R.A., Schoetz, S., DeAngelis, K., O'Neill, D., and Bank, A. (2002). Multiple hematopoietic defects and delayed globin switching in Ikaros null mice. Proc Natl Acad Sci USA 99, 602-607.
24. Luo, T., Lee, Y.H., Saint-Jeannet, J.P., and Sargent, T.D. (2003). Induction of neural crest in Xenopus by transcription factor AP2alpha. Proc Natl Acad Sci USA 100, 532-537.
25. Marsh, K.L., and Dixon, M.J. (2000). Treacher Collins syndrome. Adv Otorhinolaryngol 56, 53-59.
26. Marsh, K.L., Dixon, J., and Dixon, M.J. (1998). Mutations in the Treacher Collins syndrome gene lead to mislocalization of the nucleolar protein treacle. Hum Mol Genet 7, 1795-1800.
27. Marszalek, B., Wojcicki, P., Kobus, K., and Trzeciak, W.H. (2002). Clinical features, treatment and genetic background of Treacher Collins syndrome. J Appl Genet 43, 223-233.
28. Marszalek, B., Wisniewski, S.A., Wojcicki, P., Kobus, K., and Trzeciak, W.H. (2003). Novel mutation in the 5′ splice site of exon 4 of the TCOF1 gene in the patient with Treacher Collins syndrome. Am J Med Genet 123, 169-171.
29. Masotti, C., Armelin-Correa, L.M., Splendore, A., Lin, C.J., Barbosa, A., Sogayar, M.C., and Passos-Bueno, M.R. (2005). A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction. Gene 359, 44-52.
30. McBurney, M.W. (1993). P19 embryonal carcinoma cells. Int J Dev Biol 37, 135-140.
31. Mogass, M., York, T.P., Li, L., Rujirabanjerd, S., and Shiang, R. (2004). Genomewide analysis of gene expression associated with Tcof1 in mouse neuroblastoma. Biochem Biophys Res Commun 325, 124-132.
32. Morgan, M.J., Woltering, J.M., In der Rieden, P.M., Durston, A.J., and Thiery, J.P. (2004). YY1 regulates the neural crest-associated slug gene in Xenopus laevis. J Biol Chem 279, 46826-46834.
33. Mukhopadhyay, P., Greene, R.M., Zacharias, W., Weinrich, M.C., Singh, S., Young, W.W., and Pisano, M.M. (2004). Developmental gene expression profiling of mammalian, fetal orofacial tissue. Birth Defects Res (Part A) 70, 912-926.
34. Ness, S.A. (2003). Myb protein specificity: evidence of a context-specific transcription factor code. Blood Cells Molecules Disease 31, 192-200.
35. Numoto, M., Niwa, O., Kaplan, J., Wong, K., Merrell, K., Kamiya, K., Yanagihara, K., and Calame, K. (1993). Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins. Nucleic Acids Res 21, 3767-3775.
36. Numoto, M., Yokoro, K., and Koshi, J. (1999). ZF5, which is a Kruppel-type transcriptional repressor, requires the zinc finger domain for self-association. Biochem Biophys Res Commun 256, 573-578.
37. Obata, T., Yanagidani, A., Yokoro, K., Numoto, M., and Yamamoto, S. (1999). Analysis of the consensus binding sequence and the DNA-binding domain of ZF5. Biochem Biophys Res Commun 255, 528-534.
38. O'Neill, D.W., Schoetz, S.S., Lopez, R.A., Castle, M., Rabinowitz, L., Shor, E., Krawchuk, D., Goll, M.G., Renz, M., Seelig, H.P., Han, S., Seong, R.H., Park, S.D., Agalioti, T., Munshi, N., Thanos, D., Erdjument-Bromage, H., Tempst, P., and Bank, A. (2000). An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol Cell Biol 20, 7572-7582.
39. Paznekas, W.A., Zhang, N., Gridley, T., and Jabs, E.W. (1997). Mouse TCOF1 is expressed widely, has motifs conserved in nucleolar phosphoproteins, and maps to chromosome 18. Biochem Biophys Res Commun 238, 1-6.
40. Ramji, D.P., and Foka, P. (2002). CCAAT/enhancer-binding proteins: structure, function, and regulation. Biochem J 365, 561-575.
41. Schug, J. (2003). Using TESS to predict transcription factor binding sites in DNA sequence. In Current Protocols in Bioinformatics. A.D. Baxevanis, ed. ( John Wiley & Sons, New York), pp. 2.6.1-2.6.15.
42. Shows, K.H., Ward, C., Summers, L., Li, L., Ziegler, G.R., Hendrickx, A.G., and Shiang, R. (2006). Reduced TCOF1 mRNA level in a rhesus macaque with Treacher Collins-like syndrome: further evidence for haploinsufficiency of treacle as the cause of disease. Mamm Genome 17, 168-177.
43. So, R.B., Gonzalez, B., Henning, D., Dixon, J., Dixon, M.J., and Valdez, B.C. (2004). Another face of the Treacher Collins syndrome (TCOF1) gene: identification of additional exons. Gene 328, 49-57.
44. Speck, N.A., and Baltimore, D. (1987). Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol Cell Biol 7, 1101-1110.
45. Splendore, A., Silva, E.O., Alonso, L.G., Richieri-Costa, A., Alonso, N., Rosa, A., Carakushanky, G., Cavalcanti, D.P., Brunoni, D., and Passos-Bueno, M.R. (2000). High mutation detection rate in TCOF1 among Treacher Collins syndrome patients reveals clustering of mutations and 16 novel pathogenic changes. Hum Mutat 16, 315-322.
46. Splendore, A., Jabs, E.W., and Passos-Bueno, M.R. (2002). Screening of TCOF1 in patients from different populations: confirmation of mutational hot spots and identification of a novel missense mutation that suggests an important functional domain in the protein treacle. J Med Genet 39, 493-495.
47. Splendore, A., Fanganiello, R.D., Masotti, C., Morganti, L.S., and Passos-Bueno, M.R. (2005). TCOF1 mutation database: novel mutation in the alternatively spliced exon 6A and update in mutation nomenclature. Hum Mutat 25, 429-434.
48. Sugiura, K., Muro, Y., Nagai, Y., Kamimoto, T., Wakabayashi, T., Ohashi, M., and Hagiwara, M. (1997). Expression cloning and intracellular localization of a human ZF5 homologue. Biochim Biophys Acta 1352, 23-26.
49. Tatusova, T.A., and Madden, T.L. (1999). Blast 2 sequences - a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 174, 247-250.
50. Teber, O.A., Gillessen-Kaesbach, G., Fischer, S., Bohringer, S., Albrecht, B., Albert, A., Arslan-Kirchner, M., Haan, E., Hagedorn-Greiwe, M., Hammans, C., Henn, W., Hinkel, G.K., Konig, R., Kunstmann, E., Kunze, J., Neumann, L.M., Prott, E.C., Rauch, A., Rott, H.D., Seidel, H., Spranger, S., Sprengel, M., Zoll, B., Lohmann, D.R., and Wieczorek, D. (2004). Genotyping in 46 patients with tentative diagnosis of Treacher Collins syndrome revealed unexpected phenotypic variation. Eur J Hum Genet 12, 879-890.
51. The Treacher Collins Syndrome Collaborative Group. (1996). Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. Nat Genet 12, 130-136.
52. Valdez, B.C., Henning, D., So, R.B., Dixon, J., and Dixon, M.J. (2004). The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci USA 101, 10709-10714.
53. Wang, J., Kudoh, J., Takayanagi, A., and Shimizu, N. (2005). Novel human BTB=POZ domain-containing zinc finger protein ZNF295 is directly associated with ZFP161. Biochem Biophys Res Commun 327, 615-627.
54. Winokur, S.T., and Shiang, R. (1998). The Treacher Collins syndrome (TCOF1) gene product, treacle, is targeted to the nucleolus by signals in its C-terminus. Hum Mol Genet 7, 1947-1952.
55. Wise, C.A., Chiang, L.C., Paznekas, W.A., Sharma, M., Musy, M.M., Ashley, J.A., Lovett, M., and Jabs, E.W. (1997). TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins syndrome throughout its coding region. Proc Natl Acad Sci USA 94, 3110-3115.